Sign in

CIK 0001533040

  • Non-accelerated filer
  • Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453215903
Phone
+1 508-767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
Open-market buys, last 90 days
$86,928
in 8 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$86,928. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2013-07-05 Advanced RNA Technologies, LLC 10% owner Other disposition −18,180 $0.20 $4K 39,590,130
2013-07-03 Advanced RNA Technologies, LLC 10% owner Other disposition −50,000 $0.19 $10K 39,758,310
2013-07-03 Advanced RNA Technologies, LLC 10% owner Other disposition −50,000 $0.19 $10K 39,708,310
2013-07-02 Advanced RNA Technologies, LLC 10% owner Other disposition −9,249 $0.20 $2K 39,838,310
2013-07-02 Advanced RNA Technologies, LLC 10% owner Other disposition −30,000 $0.19 $6K 39,808,310
2013-07-01 Advanced RNA Technologies, LLC 10% owner Other disposition −50,000 $0.20 $10K 39,897,559
2013-07-01 Advanced RNA Technologies, LLC 10% owner Other disposition −50,000 $0.20 $10K 39,847,559
2013-06-28 Advanced RNA Technologies, LLC 10% owner Other disposition −46,874 $0.20 $9K 39,947,559
2013-06-27 Advanced RNA Technologies, LLC 10% owner Other disposition −50,000 $0.20 $10K 40,099,433
2013-06-27 Advanced RNA Technologies, LLC 10% owner Other disposition −60,000 $0.19 $12K 40,039,433
2013-06-27 Advanced RNA Technologies, LLC 10% owner Other disposition −45,000 $0.19 $9K 39,994,433
2013-06-26 Advanced RNA Technologies, LLC 10% owner Other disposition −50,000 $0.20 $10K 40,174,933
2013-06-26 Advanced RNA Technologies, LLC 10% owner Other disposition −25,500 $0.20 $5K 40,149,433
2013-06-25 Advanced RNA Technologies, LLC 10% owner Other disposition −50,000 $0.19 $10K 40,224,933
2013-06-07 Bitterman Robert J Director Grant or award · Stock Option (right to buy) +500,000 500,000
2013-06-07 Brownlie Keith L Director Grant or award · Stock Option (right to buy) +500,000 500,000
2013-06-07 Pavco Pamela Chief Development Officer Grant or award · Stock Option (right to buy) +2,000,000 2,000,000
2013-06-07 CAUWENBERGH GEERT President & CEO Grant or award · Stock Option (right to buy) +4,000,000 4,000,000
2013-06-07 Kontulis Caitlin Secretary & Controller Grant or award · Stock Option (right to buy) +300,000 300,000
2013-05-02 Galena Biopharma, Inc. 10% owner Sale −253,000 $0.19 $48K 32,393,095

Page 19 of 22 · 421 trades